Fig 1.
Consort flow chart.
Fig 2.
M-MSSE: Multidimensional Scale of Social Expression–Motor Part; GCBT: Group Cognitive Behavioral Therapy; GPT: Group Psychodynamic Therapy.
Table 1.
Baseline sociodemographic characteristics of the subjects.
Table 2.
Description of the evolution of symptoms in the four groups in weeks 0 and 20.
Table 3.
Number of dropouts per group at each study visit.
Fig 3.
Mean change from baseline to week 20 in Multidimensional Scale of Social Expression–Motor Part (M-MSSE) score; SER = Sertraline; PLA = Pill Placebo; GCBT = Group Cognitive-Behavioral Therapy; GPT = Group Psychodynamic Therapy; *P<0.05 **P<0.01.
Error bars represent one standard deviation.
Fig 4.
Mean change from baseline to week 20 in Scale of Avoidance and Social Discomfort (SASD) score (last observation carried forward); SER = Sertraline; PLA = Pill Placebo; GCBT = Group Cognitive-Behavioral Therapy; GST = Group Support Therapy; *P<0.05 **P<0.01.
Error bars represent one standard deviation.
Table 4.
Secondary outcomes time-by-treatment interaction (general linear model) from week 0 to week 20.